The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article
Author Archives for Adeline Chauvigné
ARRONAX PLUS: NEW TOOLS TO ENRICH THE NUCLEAR ARSENAL AGAINST CANCER
1 July 2025The objective in nuclear medicine (imaging and therapy) is to build up both a world-class research group and eventually... View Article
BIOREGATE FORUM: A GREAT SUCCESS!
In September in Nantes, an International Forum dedicated to regenerative medicine was held, bringing together 180 participants. Based on the... View Article
BIOREGATE FORUM: A GREAT SUCCESS!
1 July 2025In September in Nantes, an International Forum dedicated to regenerative medicine was held, bringing together 180 participants. Based on the... View Article
Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital
Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital Proceeds from this fundraising will be used to:... View Article
Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital
1 July 2025Horama raises €4 million with Omnes Capital, Sham Innovation Santé and GO Capital Proceeds from this fundraising will be used to:... View Article
OSE Immunotherapeutics : exercise of option within global license agreement with Janssen
OSE Immunotherapeutics announces exercise of option within global license agreement with Janssen for further clinical development of FR104 and potential commercialisation... View Article
OSE Immunotherapeutics : exercise of option within global license agreement with Janssen
1 July 2025OSE Immunotherapeutics announces exercise of option within global license agreement with Janssen for further clinical development of FR104 and potential commercialisation... View Article
OGD2 Pharma and Green Cross LabCell start collaboration
OGD2 Pharma and Green Cross LabCell start collaboration for developing NKcell therapeutics targeting the O-acetyl-GD2 cancer antigen Nantes France & Seoul... View Article
OGD2 Pharma and Green Cross LabCell start collaboration
1 July 2025OGD2 Pharma and Green Cross LabCell start collaboration for developing NKcell therapeutics targeting the O-acetyl-GD2 cancer antigen Nantes France & Seoul... View Article
Affilogic enters into a Research Collaboration and Licensing Agreement with Sanofi on Nanofitin-conjugated biotherapeutics
Affilogic announces the signature of a collaboration and license agreement with Sanofi for the development of Nanofitin®-conjugated biotherapeutics. Nantes –... View Article
Affilogic enters into a Research Collaboration and Licensing Agreement with Sanofi on Nanofitin-conjugated biotherapeutics
1 July 2025Affilogic announces the signature of a collaboration and license agreement with Sanofi for the development of Nanofitin®-conjugated biotherapeutics. Nantes –... View Article
Biofortis is pleased to announce its cooperation with Triskelion
Biofortis and Triskelion are pleased to announce the partnership signed between Biofortis, the innovation Center of Mérieux Nutrisciences, and Triskelion,... View Article
Biofortis is pleased to announce its cooperation with Triskelion
1 July 2025Biofortis and Triskelion are pleased to announce the partnership signed between Biofortis, the innovation Center of Mérieux Nutrisciences, and Triskelion,... View Article
Maryvonne Hiance Chairman of France Biotech
Atlanpole Biotherapies is pleased to announce the election of one of its iconic entrepreneur : Maryvonne Hiance, who is... View Article
Maryvonne Hiance Chairman of France Biotech
1 July 2025Atlanpole Biotherapies is pleased to announce the election of one of its iconic entrepreneur : Maryvonne Hiance, who is... View Article
Research Summer School
The University of Angers is very pleased to announce the Summer Schools Angers 2016. From 27th June to 8th July,... View Article
Research Summer School
1 July 2025The University of Angers is very pleased to announce the Summer Schools Angers 2016. From 27th June to 8th July,... View Article
CESTI IHU: INNOVATION TOWARDS IMMUNE SYSTEM MODULATION
CESTI IHU: towards an innovative therapy aiming at modulating the immune system The research program led by Prof. Karin... View Article
CESTI IHU: INNOVATION TOWARDS IMMUNE SYSTEM MODULATION
1 July 2025CESTI IHU: towards an innovative therapy aiming at modulating the immune system The research program led by Prof. Karin... View Article